RECTAL CANCER METASTATIC

This adverse event was reported 348 times

These drugs are most commonly taken by patients reporting RECTAL CANCER METASTATIC:

# Drug Count
0 OXALIPLATIN 61
1 BEVACIZUMAB 58
2 FLUOROURACIL 53
3 FLUOROURACIL CREAM, 0.5% 53
4 PANITUMUMAB 44
5 CAPECITABINE 34
6 ADALIMUMAB 25
7 INFLIXIMAB 22
8 REGORAFENIB 22
9 AZATHIOPRINE 20
See all common drugs associated with RECTAL CANCER METASTATIC

RECTAL CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEVACIZUMAB-ADCD 1 0.0049
1 PANITUMUMAB 44 0.0027
2 SOTORASIB 7 0.0020
3 REGORAFENIB 22 0.0019
4 FRUQUINTINIB 7 0.0018
5 PROCHLORPERAZINE EDISYLATE 2 0.0017
6 TRIFLURIDINE AND TIPIRACIL 16 0.0015
7 BEVACIZUMAB-AWWB 6 0.0013
8 DORAVIRINE 1 0.0013
9 BISACODYL 5MG 1 0.0011
See all drugs enriched for association with RECTAL CANCER METASTATIC